Specifically, although TCDD promotes a variety of tumors in different strains of rats, mice, and hamsters through a non-genotoxic mechanism believed to involve the Ah receptor [11, 12, 14–16], benign or malignant tumors of the prostate are not among those observed in excess in experimental animals. Here, AHR is linked to prostate cancer.